Zevra Therapeutics (ZVRA) Amortizatization of Intangibles (2024 - 2026)
Zevra Therapeutics (ZVRA) posted Amortizatization of Intangibles of $624000.0 for Q1 2026, down 27.19% on a QoQ basis from $857000.0 in Q4 2025, and up 104.59% year-over-year from $305000.0 in Q1 2025.
Zevra Therapeutics (ZVRA) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Zevra Therapeutics' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $624000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles rose 104.59% year-over-year to $624000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 188.45% YoY) and the FY2025 annual result came in at $3.1 million, up 251.46% from the prior year.
- Amortizatization of Intangibles was $624000.0 for Q1 2026 at Zevra Therapeutics, down from $857000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.2 million in Q3 2025 and bottomed at $305000.0 in Q1 2025.
- A 3-year average of $773666.7 and a median of $806000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2025 — Amortizatization of Intangibles fell 3.71% — and 2026, when it jumped 104.59%.
- Zevra Therapeutics' Amortizatization of Intangibles stood at $890000.0 in 2024, then decreased by 3.71% to $857000.0 in 2025, then dropped by 27.19% to $624000.0 in 2026.
- Business Quant data shows ZVRA's Amortizatization of Intangibles at $624000.0 in Q1 2026, $857000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Zevra Therapeutics | 570.04 Mn | 369.43 Mn | 34.32 Mn | 624,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 624,000.00 |
| Mar 31, 2026 | 624,000.00 |
| Dec 31, 2025 | 857,000.00 |
| Dec 31, 2025 | 857,000.00 |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 755,000.00 |
| Jun 30, 2025 | 755,000.00 |
| Mar 31, 2025 | 305,000.00 |
| Mar 31, 2025 | 305,000.00 |
| Dec 31, 2024 | 890,000.00 |
| Dec 31, 2024 | 890,000.00 |